Results 221 to 230 of about 1,093,681 (262)
Some of the next articles are maybe not open access.
2010
Cell-based therapies with various lymphocytes and antigen-presenting cells are promising approaches for cancer immunotherapy. The transfusion of T lymphocytes, also called adoptive cell therapy (ACT), is an effective treatment for viral infections, has induced regression of cancer in early stage clinical trials, and may be a particularly important and ...
Stephan A, Grupp, Carl H, June
openaire +2 more sources
Cell-based therapies with various lymphocytes and antigen-presenting cells are promising approaches for cancer immunotherapy. The transfusion of T lymphocytes, also called adoptive cell therapy (ACT), is an effective treatment for viral infections, has induced regression of cancer in early stage clinical trials, and may be a particularly important and ...
Stephan A, Grupp, Carl H, June
openaire +2 more sources
Cellular Engineering and Cellular Therapies
2003Cellular Engineering and Cellular Therapies - an Overview.- Gene Therapy 2002: A New Start.- Stem Cells: Potential, Selection and Plasticity.- The Potential of Stem Cell Transplantation to Rescue the Failing Liver.- The New Regulatory Environment for Cellular Therapy Products: Challenges for Academic-Based Manufacturing Facilities.- Biological ...
openaire +1 more source
Remyelination: Cellular and gene therapy
Seminars in Pediatric Neurology, 1998Dysfunctional myelination or oligodendroglial abnormalities play a prominent role in a vast array of pediatric neurological diseases of genetic, inflammatory, immunological, traumatic, ischemic, developmental, metabolic, and infectious causes. Recent advances in glial cell biology have suggested that effective remyelination strategies may, indeed, be ...
L L, Billinghurst +2 more
openaire +2 more sources
Cytotherapy, 2003
Voluntary accreditation of cells, tissues, and cellular and tissue-based products intended for human transplantation is an important mechanism for improving quality in cellular therapy. The Foundation for the Accreditation of Cellular Therapy (FACT) has developed and implemented programs of voluntary inspection and accreditation for hematopoietic ...
openaire +2 more sources
Voluntary accreditation of cells, tissues, and cellular and tissue-based products intended for human transplantation is an important mechanism for improving quality in cellular therapy. The Foundation for the Accreditation of Cellular Therapy (FACT) has developed and implemented programs of voluntary inspection and accreditation for hematopoietic ...
openaire +2 more sources
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
2009
The Foundation for the Accreditation of Cellular Therapy (FACT) was founded in 1995 to promote quality patient care and laboratory practice in hematopoietic cell transplantation (HCT) through its program of professional standards and voluntary accreditation for the procurement, processing, and transplantation of hematopoietic cell products.
openaire +1 more source
The Foundation for the Accreditation of Cellular Therapy (FACT) was founded in 1995 to promote quality patient care and laboratory practice in hematopoietic cell transplantation (HCT) through its program of professional standards and voluntary accreditation for the procurement, processing, and transplantation of hematopoietic cell products.
openaire +1 more source
Radiation therapy‐associated toxicity: Etiology, management, and prevention
Ca-A Cancer Journal for Clinicians, 2021Kyle Wang
exaly
Cellular senescence: a double-edged sword in cancer therapy
Frontiers in Oncology, 2023Jingfeng Tang, Hao Lv, Tang Jingfeng
exaly